中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Design, synthesis, and biological evaluation of novel 2-ethyl-5-phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy

文献类型:期刊论文

作者Chen, Yue-Ting; Tang, Chun-Lan; Ma, Wei-Ping; Gao, Li-Xin; Wei, Yi; Zhang, Wei; Li, Jing-Ya; Li, Jia; Nan, Fa-Jun
刊名EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
出版日期2013-11
卷号69页码:399-412
关键词Protein tyrosine phosphatase 1B Type 2 diabetes 2-Ethyl-5-phenylthiazole-4-carboxamide (PTA) SAR
ISSN号0223-5234
DOI10.1016/j.ejmech.2013.09.017
文献子类Article
英文摘要Protein tyrosine phosphatase 1B (PTP1B) is implicated as a key negative regulator of the insulin and leptin signal-transduction pathways. PTP1B inhibitors have emerged as attractive and potent pharmaceutical agents for the treatment of type 2 diabetes and obesity. We identified a series of 2-ethy1-5-phenylthiazole-4-carboxamide (PTA) derivatives, inspired from the ACT scaffold of Scleritodermin A, as a novel class of PTP1B inhibitors. Structure-activity relationship (SAR) analysis and docking studies revealed the molecular basis of PTP1B inhibition by these compounds. PTA derivative 18g was capable of inhibiting intracellular PTP1B and subsequently activating the insulin signaling pathway. Treatment of cells with 18g markedly increased the phosphorylation levels of IRP and Akt as well as the rate of glucose uptake. (C) 2013 Elsevier Masson SAS. All rights reserved.
WOS关键词INSULIN SENSITIVITY ; SCLERITODERMIN-A ; DRUG TARGETS ; BINDING-SITE ; BODY-WEIGHT ; IN-VIVO ; PTP1B ; OBESITY ; RESISTANCE ; GLUCOSE
资助项目National Natural Science Foundation of China[81125023] ; National Natural Science Foundation of China[30725049] ; National Natural Science Foundation of China[30901850] ; National Basic Research Program of China[2012CB524906] ; National Science and Technology Major Projects for Major New Drugs Innovation and Development[2013ZX09507002]
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000330603900039
出版者ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
源URL[http://119.78.100.183/handle/2S10ELR8/277385]  
专题国家新药筛选中心
中科院受体结构与功能重点实验室
新药研究国家重点实验室
通讯作者Nan, Fa-Jun
作者单位Chinese Acad Sci, Chinese Natl Ctr Drug Screening, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Chen, Yue-Ting,Tang, Chun-Lan,Ma, Wei-Ping,et al. Design, synthesis, and biological evaluation of novel 2-ethyl-5-phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2013,69:399-412.
APA Chen, Yue-Ting.,Tang, Chun-Lan.,Ma, Wei-Ping.,Gao, Li-Xin.,Wei, Yi.,...&Nan, Fa-Jun.(2013).Design, synthesis, and biological evaluation of novel 2-ethyl-5-phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,69,399-412.
MLA Chen, Yue-Ting,et al."Design, synthesis, and biological evaluation of novel 2-ethyl-5-phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 69(2013):399-412.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。